Seres Therapeutics, Inc.

Historical 13F Holders

Symbol
MCRB
CUSIP
81750R102
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 66 61.4 M $43.0 M
2024 Q4 76 63.1 M $52.5 M
2024 Q3 84 63.4 M $60.0 M
2024 Q2 100 69.3 M $50.2 M
2024 Q1 107 86.8 M $67.6 M
2023 Q4 116 90.9 M $128 M
2023 Q3 151 109 M $260 M
2023 Q2 152 112 M $538 M
2023 Q1 135 105 M $596 M
2022 Q4 137 110 M $614 M
2022 Q3 129 116 M $743 M
2022 Q2 132 90.9 M $313 M
2022 Q1 144 75.5 M $537 M
2021 Q4 171 78.1 M $650 M
2021 Q3 151 79.6 M $555 M
2021 Q2 169 86.4 M $1.93 B
2021 Q1 173 90.0 M $1.85 B
2020 Q4 168 86.8 M $2.12 B
2020 Q3 136 86.1 M $2.43 B
2020 Q2 105 72.0 M $342 M
2020 Q1 82 76.3 M $272 M
2019 Q4 84 66.7 M $230 M
2019 Q3 84 64.3 M $258 M
2019 Q2 105 62.1 M $200 M
2019 Q1 87 33.8 M $232 M
2018 Q4 74 31.9 M $144 M
2018 Q3 78 32.1 M $244 M
2018 Q2 82 32.0 M $275 M
2018 Q1 84 32.5 M $239 M
2017 Q4 88 32.1 M $326 M
2017 Q3 87 30.8 M $494 M
2017 Q2 77 30.2 M $341 M
2017 Q1 85 30.6 M $344 M
2016 Q4 95 31.2 M $309 M
2016 Q3 102 31.2 M $383 M
2016 Q2 96 31.5 M $916 M
2016 Q1 81 30.9 M $822 M
2015 Q4 76 29.3 M $1.03 B
2015 Q3 62 13.8 M $409 M
2015 Q2 45 11.4 M $471 M